Fmr LLC Roivant Sciences Ltd. Transaction History

Fmr LLC

$1.52 Trillion
Q2 2024

A detailed history of Fmr LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Fmr LLC holds 46,551,146 shares of ROIV stock, worth $544 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

46,551,146

Previous 35,340,563 31.72%

Holding current value

$544 Million

Previous $372 Million 32.1%

% of portfolio

0.03%

Previous 0.03%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$10.36 - $11.74 $116 Million - $132 Million	11,210,583 Added 31.72%	46,551,146 $492 Million
Q1 2024 May 13, 2024	SELL	$9.87 - $11.8 $16.1 Million - $19.3 Million	-1,635,685 Reduced 4.42%	35,340,563 $372 Million
Q4 2023 Feb 13, 2024	SELL	$8.38 - $11.58 $16.2 Million - $22.4 Million	-1,934,377 Reduced 4.97%	36,976,248 $415 Million
Q3 2023 Nov 13, 2023	BUY	$9.76 - $13.19 $28.4 Million - $38.4 Million	2,913,491 Added 8.09%	38,910,625 $454 Million
Q2 2023 Aug 11, 2023	BUY	$7.09 - $10.08 $37.1 Million - $52.8 Million	5,234,850 Added 17.02%	35,997,134 $363 Million
Q1 2023 May 11, 2023	BUY	$6.92 - $9.98 $2.7 Million - $3.9 Million	390,794 Added 1.29%	30,762,284 $227 Million
Q4 2022 Feb 13, 2023	BUY	$3.36 - $7.99 $88 Million - $209 Million	26,196,460 Added 627.46%	30,371,490 $243 Million
Q3 2022 Nov 10, 2022	BUY	$0.51 - $4.84 $854,265 - $8.11 Million	1,675,030 Added 67.0%	4,175,030 $13.4 Million
Q4 2021 Feb 14, 2022	BUY	$5.86 - $13.52 $14.7 Million - $33.8 Million	2,500,000 New	2,500,000 $25.2 Million

Others Institutions Holding ROIV

# of Institutions

314

Shares Held

496M

Call Options Held

991K

Put Options Held

1.15M

View Full List

About Roivant Sciences Ltd.

Ticker ROIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 704,382,976
Market Cap $8.23B
Description
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...

More about ROIV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account